HB0034 for severe pustular psoriasis flare
Treatments studied
Part of Skin clinical trials.
This study tests an experimental drug called HB0034 for people with a sudden, severe flare of generalized pustular psoriasis (GPP). It aims to see if the drug can safely clear the pustules and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently having a moderate-to-severe flare of pustular psoriasis (new or worsening pustules covering at least 5% of your body).
- You are willing to use reliable birth control during the study and for 6 months after the last dose (if you could become pregnant or get someone pregnant).
- You are not pregnant or breastfeeding.
- You do not have other active autoimmune diseases (like rheumatoid arthritis, lupus, or inflammatory bowel disease) that require immune-suppressing treatment.
- You are not at high risk for serious infections (e.g., from HIV, organ transplant, or recent severe infection).
- You have not had a live vaccine in the past 6 weeks and do not plan to get one during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people who have already taken part in an earlier study of the drug HB0034 for generalized pustular psoriasis (GPP). It checks how safe and effective the drug is over a longer period of time.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
This study tests an investigational oral medication called HS-10374 for moderate to severe plaque psoriasis. It aims to see how well it clears skin and prevents flares compared to a placebo, and if it is safe for long-term use.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This trial tests a new medication called HB0017 for moderate to severe plaque psoriasis. It aims to see if it is safe and effective in reducing skin symptoms and improving quality of life.
Hear when a new Generalized Pustular Psoriasis (GPP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.